The Hydration Pharmaceuticals Company Limited (HPC.AX)

AUD 0.01

(0.0%)

EBITDA Summary of The Hydration Pharmaceuticals Company Limited

  • The Hydration Pharmaceuticals Company Limited's latest annual EBITDA in 2023 was -7.45 Million USD , up 29.07% from previous year.
  • The Hydration Pharmaceuticals Company Limited's latest quarterly EBITDA in 2024 Q2 was -1.00 USD , up 100.0% from previous quarter.
  • The Hydration Pharmaceuticals Company Limited reported an annual EBITDA of -10.51 Million USD in 2022, down -97.55% from previous year.
  • The Hydration Pharmaceuticals Company Limited reported an annual EBITDA of -6.08 Million AUD in 2021, down -62.48% from previous year.
  • The Hydration Pharmaceuticals Company Limited reported a quarterly EBITDA of -1.00 USD for 2024 Q1, up 100.0% from previous quarter.
  • The Hydration Pharmaceuticals Company Limited reported a quarterly EBITDA of -411.04 Thousand USD for 2023 Q3, down -278.1% from previous quarter.

Annual EBITDA Chart of The Hydration Pharmaceuticals Company Limited (2023 - 2018)

Historical Annual EBITDA of The Hydration Pharmaceuticals Company Limited (2023 - 2018)

Year EBITDA EBITDA Growth
2023 -7.45 Million USD 29.07%
2022 -10.51 Million USD -97.55%
2021 -6.08 Million AUD -62.48%
2020 -3.27 Million USD 3.32%
2019 -3.38 Million USD 63.09%
2018 -9.18 Million USD 0.0%

Peer EBITDA Comparison of The Hydration Pharmaceuticals Company Limited

Name EBITDA EBITDA Difference
Metcash Limited 624.6 Million AUD 101.194%